GlassScriptPhysician profile
Beverly Whittenberg
NPI 1366483034
$9,885.08
in general payments reported to CMS, 2019-2025
52 companies · $1,755 in 2025
The $1,755 reported for 2025 was more than what 75% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,388 · 2020: $757 · 2021: $1,338 · 2022: $2,678 · 2023: $948 · 2024: $1,020 · 2025: $1,755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,723.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $1,274.58 | 2022 | |
| Abbvie INC. | $1,130.08 | 2022-2025 | Ubrelvy, Qulipta, Botox |
| Medtronic, INC. | $875.23 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Inceptiv |
| Collegium Pharmaceutical, INC. | $814.94 | 2019-2025 | Xtampza, Belbuca |
| Abbott Laboratories | $656.49 | 2019-2025 | Proclaim |
| Ibsa Pharma INC. | $377.64 | 2020-2025 | Tirosint, Licart, Licart |
| Vertos Medical, INC. | $371.70 | 2021-2024 | Mild Device Kit |
| Nevro Corp. | $339.08 | 2019-2024 | Senza |
| Scilex Pharmaceuticals INC. | $308.72 | 2019-2022 | |
| Medtronic USA, INC. | $306.32 | 2019-2020 | |
| Pfizer INC. | $290.10 | 2019-2025 | |
| Globus Medical, INC. | $214.10 | 2025 | Senza |
| Grt US Holding, INC. | $202.14 | 2021-2022 | |
| Foundation Fusion Solutions, LLC | $191.67 | 2022 | |
| Biotronik Nro, INC. | $170.72 | 2025 | Prospera |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $162.67 | 2020-2022 | |
| Boston Scientific Corporation | $148.60 | 2019-2025 | Wavewriter Alpha Prime 16, Artisan |
| Almatica Pharma LLC | $143.87 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $135.39 | 2019-2024 | Relistor |
| Allergan, INC. | $130.36 | 2019-2021 | |
| Assertio Therapeutics, INC. | $128.59 | 2019 | |
| Bioventus LLC | $122.45 | 2023-2025 | Stimrouter Implantable Kit, Durolane |
| Teva Pharmaceuticals USA, INC. | $115.94 | 2019-2020 | |
| Spinal Simplicity, LLC | $108.92 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $99.51 | 2024 | Iovera |
| Axogen | $90.90 | 2024 | Axoguard Nerve Cap, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Providence Medical Technology, INC. | $79.78 | 2022 | |
| Arbor Pharmaceuticals, INC. | $79.55 | 2019-2021 | |
| Averitas Pharma INC. | $76.76 | 2023-2025 | Qutenza |
| Lundbeck LLC | $69.81 | 2025 | Vyepti |
| Amgen INC. | $67.06 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $58.43 | 2019-2021 | |
| Depuy Synthes Sales INC. | $52.52 | 2019-2024 | Peak, Monovisc, Orthovisc |
| Mdd US Operations, LLC | $46.43 | 2019 | |
| Hikma Pharmaceuticals USA | $44.40 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $43.69 | 2024-2025 | |
| Horizon Therapeutics Plc | $40.91 | 2020-2021 | |
| Redhill Biopharma INC. | $34.84 | 2021 | |
| Stryker Corporation | $30.60 | 2025 | Mild Device Kit |
| Radius Health, INC. | $25.92 | 2019-2020 | |
| Si-Bone, INC. | $24.77 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.81 | 2019 | |
| Protega Pharmaceutials INC | $21.00 | 2024 | Roxybond |
| Valinor Pharma, LLC | $20.99 | 2025 | Movantik |
| Baudax Bio INC. | $20.78 | 2020 | |
| Pacira Therapeutics, INC. | $19.60 | 2020 | |
| Ferring Pharmaceuticals INC. | $19.59 | 2021 | |
| Azurity Pharmaceuticals, INC. | $19.46 | 2023 | Horizant |
| Daiichi Sankyo INC. | $16.98 | 2019 | |
| Curonix LLC | $13.75 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Shionogi INC | $13.00 | 2019 | |
| Electronic Waveform Lab, INC. | $11.94 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beverly Whittenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.